# Advanced CRISPR Applications: A Review

Ce fichier demontre les differentes syntaxes de citations supportees, incluant le groupement automatique des citations adjacentes.

## Introduction

Gene editing technologies have transformed modern medicine. Several recent studies have explored various aspects of CRISPR-Cas9 therapy [@pmid:41524770] [@pmid:41524478] [@pmid:41481737].

> **Resultat attendu avec style numerique:** Les citations adjacentes sont automatiquement groupees en `(1-3)` au lieu de `(1) (2) (3)`.

## Off-Target Effects

One of the main concerns with CRISPR is off-target editing. Basit et al. [@pmid:41524770] extensively reviewed the challenges and strategies for precision DNA editing. Their work highlights the importance of careful guide RNA design.

## Delivery Methods

Efficient delivery remains a challenge. Kim et al. [@pmid:41524478] developed lipid-silica hybrid nanoparticles for CRISPR delivery. This approach complements the high-fidelity Cas9 variants described by Qi et al. [@pmid:41481737].

## Therapeutic Potential

The therapeutic applications of CRISPR are vast [@pmid:41476860] [@pmid:41465342]. As noted earlier by Basit et al. [@pmid:41524770], minimizing off-target effects is crucial for clinical translation.

## Discussion

Multiple groups have contributed to advancing CRISPR technology [@pmid:41524770] [@pmid:41481737] [@pmid:41476860]. The work by Basit et al. [@pmid:41524770] on off-target effects, combined with the delivery innovations from Kim et al. [@pmid:41524478], suggests that clinical applications are within reach.

---

## Exemples de syntaxes de groupement

Les exemples de syntaxe sont documentes dans `overview.md`. Voici une demonstration avec de vraies citations:

### Citations adjacentes groupees

Ces trois citations adjacentes: [@pmid:41524770] [@pmid:41524478] [@pmid:41481737]
sont rendues comme un groupe `(1-3)` au lieu de `(1) (2) (3)`.

### Citations non-groupees (separees par texte)

Voir [@pmid:41524770], puis voir aussi [@pmid:41524478].

Ces deux citations sont separees par du texte/ponctuation, donc elles ne sont PAS groupees.

---

## Conclusion

CRISPR-Cas9 continues to evolve rapidly. From the foundational work on precision [@pmid:41524770] to novel delivery systems [@pmid:41524478] and therapeutic applications [@pmid:41476860] [@pmid:41465342], the field shows tremendous promise.
